CV- ELI SCHWARTZ, MD, DTMH
LIST OF PUBLICATIONS-according to subjects (partial list)
Parasitic Diseases
Malaria:
1. Schwartz E., Golenser Y.
Treatment of malaria.
Harefu'ah, 124, 572-577, 1993.
2. Duer D., Schwartz E., Shaked N., Ramot B.
Amodiaquin-induced agranulocytosis: Drug inhibition of myloid colonies in the
presence of patient's serum.
Israel. J. of Medical Science. 21: 331-334, 1985.
3. Schwartz E., Shapiro R., Shina S., Bank, I.
Delayed Expansion of Vδ2+ and Vδ1+ γδ T cells after acute Plasmodium falciparum
and Plasmodium vivax malaria.
J. of Allergy and Clinical Immunology 97, 1387-1392, 1996.
4. Schwartz E., Pener H., Issa M.S., Golenser J.
An overview of the malaria situation in Zanzibar.
J. of Community Health 22, 33-44, 1997.
5. Golesner J., Peled-Kamar M., Schwartz E., Friedman H., Groner Y., Pollack Y.
Transgenic mice with elevated level of CuZnSOD are highly susceptible to malaria
infection.
Free Radicals Biology and Medicine .24,1504-1510,1998.
6. Schwartz E., Sidi. Y.
New aspects of malaria imported from Ethiopia.
Clinical Infectious Disease.26, 1089-1091, 1998.
7. Weber G., Schwartz E., Schlaffer F., Lang R., Alkan M.
Imported severe Plasmodium falciparum malaria in Israel.
J. of Travel Medicine. 5, 97-99, 1998.
8. Schwartz E., Samuni A., Friedman I., Hempelmann E., Golenser Y.
Deleterious role of superoxide dismutation in malaria parasites.
Inflamation .23: 361-370, 1999.
-1
Short CV- ELI SCHWARTZ, MD, DTMH
9. Schwartz E., Regev-Yochay G.,
Primaquine as prophylaxis for malaria for non-immune travelers; comparison to
mefloquine or doxycycline
Clinical Infectious Disease. 29, 1502-1506, 1999
10. Schwartz E., Regev-Yochay G., Kurnik D.
Considering primaquine dose adjustment for radical cure of Plasmodium vivax
malaria. American . J. of Tropical Medicine and Hygiene. 62, 393-5, 2000
11. Schwartz E., Paul F., Pener H., Almog S., Rotenberg M., Golenser J.
Malaria antibodies and mefloquine levels among United Nations troops in Angola.
J. Travel Medicine. 8:113-116, 2001
12. Schwartz E. ,Potasman I.., Rotenberg M., Almog S., Sadetzki S.
Serious adverse events of mefloquine in relation to blood level and gender.
American . J. of Tropical Medicine and Hygiene. 65;189-192,2001
13. Schwartz E. Sadetzki S Murad H,. Raveh D.
Age as risk factor for severe malaria.
Clinical Infectious Diseases. 33; 1774-7, 2001
14. Schwartz E.
Primaquine for malaria prophylaxis.
In Travelers’ Malaria (P. Schlagenhauf Editor)
B C Decker Inc. Canada, 2001 (Revised 2007)
15. Potasman I, Yuven Y, Weller B, Heidecker J, Schwartz E.
Does Mefloquine Prophylaxis Affect Electro-Encephalographic Patterns?
American J. of Medicine, 112:147-149 , 2002
16. Schwartz E.,
Malaria in Israel- Can we prevent the severe morbidity and mortality ?
Harefua- (Editorial)- 141: 699-701, 2002
17. Bujanover S, Schwartz E.,
Rapid test for Malaria
Isr Med Assoc J. 4; 1167: 2002
18. Schlagenhauf P., Tschopp A., Johnson R., Nothdurft HD,Beck B., Schwartz E,
Herold M, Krebs B, Veit O, Allwinn R, Steffen R.
Tolerability of malaria chemoprophylaxis in non-immune travelers to sub-Saharan
Africa: a randomised, double-blind, four-arm study.
Br. Med. J. – 327;1078-1083, 2003
19. Schwartz E ,Bujanover S.,Kain K
Genetic Confirmation of Atovaquone–proguanil (Malarone™) resistant Plasmodium
falciparum malaria acquired by a non-immune traveler to East Africa.
-2
Short CV- ELI SCHWARTZ, MD, DTMH
Clinical Infectious Diseases- 37; 450-1, 2003
20. Eli Schwartz, Praise M., Kozarsky P, Cetron M.
Delayed onset of malaria: Implications for chemoprophylaxis
in travelers.
New Engl. J. Med.- 349: 1510-6, 2003
21. Elliott JH, O’Brien D, Leder K, Kitchener S, Schwartz E, Weld L,
Brown GV, Torresi J. for the GeoSentinel Surveillance Network.
Imported Plasmodium vivax malaria: demographic and clinical features in
non-immune travellers
J. of Travel Medicine -11:213-219, 2004
22. Leder K, Black J, O’Brien D, Greenwood Z, Kain K, Schwartz E., Brown G,
Torresi J. Malaria in travelers: a review of the GeoSentinel Surveillance Network.
Clinical Infectious Diseases- 39:1104-12, 2004
23. Schwartz E.
Malaria – a disease that refuses to die but continues to kill.[Editorial]
Isr Med Assoc J. 2005
24. Baird K, Schwartz E, Hoffman S.
Prevention and treatment of vivax malaria.
Curr Infect Dis Rep. 9(1):39-46, 2007
25. Schlagenhauf, P, Johnson R, Schwartz E, Nothdurft HD, Steffen R.
Evaluation of mood profiles during malaria chemoprophylaxis : a randomised,
double-blind, four-arm study.
J. Travel Med- - 16(1):42-5, 2009
26. E Kopel, E Schwartz, Z Amitai, I Volovik
Relapsing vivax malaria cluster in Eritrean refugees, Israel June 2010.
Eurosurveillance, Volume 15, Issue 26, 01 July 2010.
27. Sabbag A, Schwartz E.
The awareness of malaria in primary care medicine].
Harefuah. 2010 Sep;149(9):568-71, 621, 620. Hebrew.
28. Altman A, Gueta I, Grosman T, Schwartz E.
Acute respiratory distress syndrome (ARDS) as a complication of malaria P.vivax].
Harefuah. 2010 Sep;149(9):580-2, 620. Hebrew.
29. Neuberger A, Zaolan O, Tenenboim S, Vernet S, Pex R, Held K, Urman M,
Garpenfeldt
K, Schwartz E .
Malaria among patients and aid workers consulting a primary healthcare center in
-3
Short CV- ELI SCHWARTZ, MD, DTMH
Leogane, Haiti, November 2010 to Febuary 2011 – a prospective observational study.
Eurosurveillance, Volume 16, Issue 13, 31 March 2011
30. Eyal leshem, Nathan Keller, Daphna Guthman, Tamar Grossman,Michal Solomon,
Esther Marva, Eli Schwartz
False Positive Plasmodium falciparum Histidine-Rich Protein 2 Immunocapture Assay
in Acute Schistosomiasis Caused by Schistosoma mekongi
J. Clin. Micrbiol. 49(6):2331-2, 2011
31. Eran Kopel, Enbal Marhoom Yechezkel Sidi and Eli Schwartz
Successful oral therapy for severe falciparum malaria:
The World Health Organization criteria revisited
Am J Trop Med Hyg. 2012
Schistosomiasis:
32. Schwartz E. Rozenman J, .Perelman N.
Pulmonary manifestations of early schistosoma infection among nonimmune
travelers.
American J. of Medicine 109, 718-722, 2000.
33.
Schwartz E.
Pulmonary Schistosomiasis
Clinics in Chest Medicine, 23; 433-443, 2002
34. Schwartz E. Rozenman J.
Schistosomiasis
N. Engl. J. Medicine, 347;766-768, 2002
35. Schwartz E, Pick N, Shazberg G, Potasman I,
Hematospermia Due to Schistosome Infection in Travelers:
Diagnostic and Treatment Challenge.
Clinical Infectious Diseases. 35;1420-4, 2002
36. Schwartz E.
Hematospermia caused by schistosomiasis in travelers
[Clinical Insights, Contemporary Topics]. MD Consult Infectious Disease.
November 3, 2003. Available at: http://www.mdconsult.com
37. Schwartz E., Kozarsky P, Wilson M, Cetron MD.
Schistosome infection among river rafters on the Omo River, Ethiopia
J. of Travel Medicine – 12: 3-8, 2005.
-4
Short CV- ELI SCHWARTZ, MD, DTMH
38. Meltzer E, Artom G, Marva E , Assous M, Rahav G , Schwartz E.
Schistosomiasis in travelers - new aspects of an old disease
Emerging Infectious Diseases. 12; 1696-1700, 2006
39. Schwartz E.
Lung Involvement in schistosomiasis (Chapter)
In: Om P. Sharma ed. Tropical Lung Disease 2nd edition
Taylor & Francis Group. New York, 2006
40. Meltzer E, Schwartz E.
Enteric fever: an Israeli perspective (Review)
Isr Med Assoc J. 9:736–741, 2007
41. Nicolls DJ., Weld L, Schwartz E , Reed C, Sonnenburg F, Kozarsky P, for the
GeoSentinel Surveillance Network
Schistosomiasis in Travelers: a review of patients reported to the GeoSentinel
Surveillance Network.
Am J Trop Med Hyg.79(5):729-34, 2008
42. Leshem E, Maor Y, Meltzer E, Assous M, Schwartz E.
Acute schistosomiasis outbreak: clinical features and economic impact.
Clin Infect Dis. 15;47(12):1499-506, 2008
43. Leshem E, Meltzer E, Marva E, Schwartz E,
Travel-Related Schistosomiasis Acquired in Laos
Emerging Infectious Diseases..15(11):1823-6. 2009
Leishmania & Myiasis:
44. Schwartz E., Gur H
D. hominis Myiasis Among Israeli Travelers to South America: An Emerging Disease in
the Amazon Basin of Bolivia.
J. of Travel Medicine 9: 97-99, 2002
45. Tamir J., Haik J., Orenstein A., Schwartz E.,
Dermatobia Hominis Myiasis among travelers returning from South America.
J. American academy of Dermatology- 48: 630-632; 2003
46. Scope A, Trau H, Andreas G., Konfino Y., Barzilay A., Schwartz E.
Experience with New World Cutaneous Leishmaniasis in Israeli Travelers.
J. Am Acad Dermatol- 49: 672-8, 2003
-5
Short CV- ELI SCHWARTZ, MD, DTMH
47. Scope A, Trau H, Bakon M, Yarom N, A. Nasereddin. Schwartz E.
Imported Mucosal Leishmaniasis in a Traveler
Clinical Infectious Diseases- 37: e83-7, 2003
48. Jeremy Tamir, Josef Haik, Eli Schwartz,
Myiasis with Lund's fly (Cordylobia rodhaini) in Travelers.
J. of Travel Medicine - 10:293-5, 2003
49. Blum J, Desjeux Ph., Schwartz E., Beck B., Hatz Ch.
Treatment of cutaneous leishmaniasis.
J. Antimicrobial Chemotherapy-53, 158-66,2004
50. Shani Adir A, Rozenman D, Kamil S, Schwartz E., Ramon M, Zalman L,
Nasereddin A, Jaffe CL, Ephros M.
Leishmania tropica in northern Israel– a clinical overview of an emerging focus
J. American academy of Dermatology -53, 810-15,2005
51. Eli Schwartz
Leishmaniasis in Israel (Editorial)
J. Israeli Military Medicine, 2005
52. Schwartz E., Hatz C, Blum J.
New World Cutaneous Leishmaniasis in Travellers
The Lancet Infectious Diseases; 6:342-9, 2006
53. Solomon M, Baum S, Barzilai A , Scope A, Trau H, Schwartz E
Liposomal Amphotericin B in comparison to Sodium Stibogluconate for
Treatment of Cutaneous Leishmaniasis due to L. Braziliensis
J. American academy of Dermatology –56;612-616, 2007
54. Bar Daroma E, Wilamowski A, Schnur H, Yarom N, Scheuer E, Schwartz E.
Oral Myiasis:A case report and literature review
Oral Surg Oral Med Oral Pathol Oral Radiol Endod.- 103; 92-6, 2007
55. Solomon M, , Trau H, Schwartz E
Old-World cutaneous leishmanisis: An ancient disease in wait of new drug
Annales de dermatologie et de venereologie, 135; 357-359, 2008
56. Solomon M, Baum S, Barzilai A , Pavlotzki F, Trau H, Schwartz E.
Treatment of cutaneous Leishmaniasis with Intralesional Pentostam in Israel
J Eur Acad Dermatol Venereol. (10):1189-92. 2009
57. Solomon M, , Pavlotzki F, Leshem E, Ephros M, Trau H, Schwartz E
Liposomal amphotericin B treatment of cutaneous leishmaniasis due to Leishmania
Tropica
J Eur Acad Dermatol Venereol.-2010
-6
Short CV- ELI SCHWARTZ, MD, DTMH
Others:
58. Schwartz E., Shlim D.R.
Tick bite appendicitis (Case report).
J. of the American Medical Association. 259,24: 3561, 1988.
59. Houston R., Schwartz E.
Helmenthic infection among Peace Corp volunteers in Nepal.
J. of the American Medical Association. 263, 373-374, 1990.
60. Schwartz E., Houston R.
The effect of co-trimoxazole on stool recovery of Blastocystis hominis.
Lancet, 339, 428-429, 1992
61. Meltzer E., Perchik R, Shatzkes J. Sidi Y. Schwartz E.
Eosinophilia among returning travelers – a practical approach
American . J. of Tropical Medicine and Hygiene – 2008 ;78(5):702-9
62. Leshem E, Kliers I, Bakon M, Zucker T, Potasman I, Schwartz E.
Neurocysticercosis in Israel]
Harefuah. 2010 Sep;149(9):576-9, 620. Hebrew.
63. Leshem E, Kliers I, Bakon M, Gomori M, Karplus R, Schwartz E.
Neurocysticercosis in travelers: a nation-wide study in Israel.
J Travel Med. 2011 May-Jun;18(3):191-7
64. Meltzer E., Steinlauf S, Michaeli S, Leshem E, Sidi Y, Schwartz E
Human African Trypanosomiasis in a traveler: diagnostic pitfalls.
Am J Trop Med Hyg. 2012
Viral Infection
Dengue fever:
65. Schwartz E., Mendelson E., Sidi Y.
Dengue fever among travelers.
American J. of Medicine 101, 516-520, 1996.
66. Potasman I., Srugo I., Schwartz E.
Dengue seroconversion among Israeli travelers to tropical countries.
Emerging Infectious Diseases.5, 824-7,1999.
-7
Short CV- ELI SCHWARTZ, MD, DTMH
67. Schwartz E., Mileguir F., Grossman Z., Mendelson E .
Evaluation of serological-based diagnosis of dengue fever among travelers.
J. Clin. Virology. 19, 169-173, 2000.
68. Schwartz E. Moskovitz A.,Potasman I., Peri G., Grossman Z., Alkan M.L.
The changing epidemiology of dengue fever in travelers to Thailand.
Eur.J.Clinical Microbiology .& Infectious Diseases. 19, 784-786, 2000
69. Schwartz E.
Study of Dengue Fever among Israeli Travellers to Thailand
WHO, Dengue Bulletin, 26; 162-167, 2002
70. Wilder-Smith A, Schwartz E.
Dengue in travelers.
New Engl. J. Med – 353:924-32, 2005
71. Tanai A, Schwartz E., Bin H., Zeller H, Niedrig M, Dan M.
Chikungunia fever in Israeli travelers returning from north-western India
J. of Travel Medicine , 2008 ;15(5):382-4
72. Eli Schwartz, Leisa Weld, Wilder-Smith A, von Sonnenburg F, Keystone JS, Kain
KC, Torresi J, and Freedman DO for the GeoSentinel Surveillance Network.
Seasonality, Annual Trends, and Characteristics of Dengue in Ill Returned Travelers.
Emerging Infectious Diseases.. 2008 ;14(7):1081-8.
73. Meltzer E, Schwartz E.,
A travel medicine view of Dengue and Dengue hemorrhagic fever
Trop Med Inf Dis- (5):278-83. 2009 (Review).
74. Leshem E, Bin H, Shalom U, Perkin M, Schwartz E
Risk for Dengue and Chikungunya in Israel
Emerging Infectious Diseases, 18(2):345-7, 2012
75.Meltzer E, Bin H. Schwartz E
Capillary leakage in Travelers with Dengue Infection :
Implications for pathogenesis
Am J Trop Med Hyg. 2012
Viral hepatitis:
76. Schwartz E., Shlim D.R., Innis B., Eaton M.
Viral hepatitis in foreign residents and travellers in Nepal.
J. of Wilderness Medicine. 2, 88-93, 1991.
-8
Short CV- ELI SCHWARTZ, MD, DTMH
77. Schwartz E., Yaron I., Galun E.
Hepatitis E virus (review).
Harefu'ah 127, 149-151, 1994.
78. Schwartz E., Galun E.
Prior hepatitis A virus infection enhances acute hepatitis E virus infection.
Medical Hypothesis, 42, 198-202, 1994.
79. Karetnyi Y.V., Favorov M.O., Khudyakova N.S., Weiss P., Bar-Shani S.,
Handsher R., Aboudy Y., Varsano N., Schwartz E., Levin E., Mendelson E.,
Fields H.A.
Serological evidence for hepatitis E infection in Israel.
J. of Medical Virology. 45, 316-320, 1995.
80. Schwartz E., Raveh D.
The prevalence of hepatitis A antibodies among Israeli travelers and the
economic feasibility of screening before vaccination
International J. of Epidemiology. 27, 118-120, 1998.
81. Schwartz E., Piper-Jenks N.
Simultaneous amebic liver abscess and hepatitis A infection.
J. of Travel Medicine. 5, 95-96, 1998.
82. Schwartz E., Piper-Jenks N. Van damme P., Galun E.
Hepatitis E virus infection among travelers.
Clinical Infectious Disease. 29, 1312-1314, 1999.
83. Piper-Jenks N. Horowitz H. Schwartz E.
The risk of hepatits E virus infection among travelers.
J. of Travel Medicine. 7, 194-99, 2000 (see attached Editorial on it)
Others:
84. Shlim D.R., Schwartz E., Houston R.
Rabies immunoprophylaxis strategy in travelers.
J. of Wilderness Medicine. 2, 15-21, 1991.
85. Gautret P, Schwartz E, Shaw M, Soula G, Gazin P. Delmont J , Parola P , Soavi
JM, Matchett E, Brown G and Torresi J for the GeoSentinel Surveillance Network.
Animal-associated injuries and related diseases among returned travellers: A
review of
the GeoSentinel Surveillance Network
Vaccine- 25;2656-2663, 2007
-9
Short CV- ELI SCHWARTZ, MD, DTMH
Bacterial Infection
Typhoid Fever:
86. Schwartz E., Shlim D.R., Eaton M., Jenks N., Houston R.
The effect of oral and parenteral typhoid vaccination on the rate of infection with
Salmonella typhi and Salmonella paratyphi A among foreigners in Nepal.
Archives of Internal Medicine. 150, 349-51, 1990.
87. Schwartz E., Shlim D.R.
Enteric fever among Israeli travellers in Nepal: The need for typhoid vaccination.
Israel. J. of Medical Science. 26, 325-27, 1990.
88. Schwartz E.
Typhoid vaccine - a double-edged sword?
Israel. J. of Medical Science. 26, 645-46, 1990
89. Schwartz E., Piper Jenks N., Shlim DR.,
Typhoid hepatitis or typhoid fever and acute viral hepatitis.
Transactions of the Royal Society of Tropical Medicine and Hygiene.88:437-438,
1994.
90. Shlim D.R., Schwartz E., Eaton M.
Clinical importance of Salmonella paratyphi A infection to enteric fever in Nepal.
J. of Travel Medicine 2, 1665-168, 1996.
91. Meltzer E., Sadik C, Schwartz E.
Enteric Fever in Israeli Travelers: a Nation-Wide study
J. of Travel Medicine – 12:275-81 , 2005
92. Meltzer E. Yosipovitch O., Sadik C., Dan M, Schwartz E.
Epidemiology and clinical aspects of Typhoid Fever in Israel.
American . J. of Tropical Medicine and Hygiene 74; 540-45, 2006
93. Meltzer E, Schwartz E.
Typhoid fever in Israel (Review)
Isr Med Assoc J. 9:736–741, 2007
94. Connor BA, Schwartz E.
Typhoid and paratyphoid fever in Travellers
The Lancet Infectious Diseases-5,623-8, 2005
95. Meltzer E, Schwartz E.
Enteric fever: an Israeli perspective (Review)
-10
Short CV- ELI SCHWARTZ, MD, DTMH
Isr Med Assoc J. 9:736–741, 2007
96. Schwartz E. Connor BA.
Typhoid infection.
BMJ Point-of-Care ;2008 www.pointofcare.bmj.com
97. Galmor O, Suez J, Elhadad D, Porwollik S, Leshem E, Valinsky L, McClelland M,
Schwartz E, Rahav G.
Molecular and Cellular Characterization of a Salmonella enterica Serovar Paratyphi A
outbreak Strain and the Human Immune Response to its Infection.
Clinical & Vaccine Immunology 2012
Spirochete (Leptospirosis & Relapsing Fever)
98. Kariv R, Klempfner R., Barnea A. Sidi Y, Schwartz E.
The changing epidemiology of leptospirosis in Israel.
Emerging Infectious Diseases. 7; 990- 992, 2001
99. Hadad E.,Pirogovsky A, Bartal C, Gilad J, Barnea A, Itzhaki S, Grotto I,
Balicer R, Schwartz E.
Leptospirosis among Israeli troops trained in the Jordan river.
American . J. of Tropical Medicine and Hygiene –74: 127-31, 2006
100. Sidi G, Balicer R, , Davidovitch N, Anis E, Grotto I, Schwartz E.
The Epidemiology of Tick-Borne Relapsing Fever in Israel
Emerging Infectious Diseases. 11; 1784-6, 2005
101. Hadad E.,Pirogovsky A, Bartal C, Gilad J, Barnea A, Itzhaki S, Grotto I,
Balicer R, Schwartz E.
Leptospirosis among Israeli troops trained in the Jordan river.
American . J. of Tropical Medicine and Hygiene –74: 127-31, 2006
102. Sidi G, Balicer R, , Davidovitch N, Grotto I, Schwartz E.
Tick-Borne Relapsing Fever in Israeli Defence Forces
J. Israel Miltary Medicine., 3; 51-55, 2006
103. Leshem E, Segal G, Barnea A, Yitzhaki S. , Ostfeld I , Pitlik S, Schwartz E.
Travel-Related Leptospirosis in Israel: A Nationwide Study
Am J Trop Med Hyg. 2010- In press
Others:
104. Fanny D., Thomas L., Schwartz E.
-11
Short CV- ELI SCHWARTZ, MD, DTMH
An outbreak of pyomyositis in a large refugee camp in Thailand.
American . J. of Tropical Medicine and Hygiene. 33: 131-133, 1982.
105. Somekh E., Lev B., Schwartz E., Barzilai A., Rubinstein E.
The effect of ciprofloxacin and pefloxacin on bone marrow engraftment in the spleen of
mice.
J. of Antimicrobial Chemotherapy. 23:247-51, 1989
106. Moualem M., Friedman E., Pausner R., Schwartz E., Rubinstein E.:
Rickettsiosis- associated hyponatremia.
Infection 15,5: 315-316, 1987.
107. Schwartz E, Bar-El D, Schur N.
The History of Cholera Epidemics in Israel
Harefuah,-144:, 363-70, 2005
108. Jensenius M, Davis X, Sonnenburg F, Schwartz E,. Keystone JS, Leder K, LopézVéléz R, Caumes E,. Cramer JP, Chen L, Parola P, for the GeoSentinel Surveillance
Network*
Rickettsial diseases in international travellers: the GeoSentinel
experience 19962008
Emerging Infectious Diseases.. 2009
109. Meltzer E, Sidi Y, Smolen G, Banai M, Schwartz E
Sexually transmitted Brucellosis in humans
Clin Infect Dis. 2010 –in press
110. Atias D, Meltzer E, Leshem E, Schwartz E.
Rickettsia africae infection among participants in a women's safari to South Africa].
Harefuah. 2010 Sep;149(9):572-5, 620. Hebrew.
111. Leshem E, Meltzer E, Schwartz E
Travel-associated zoonotic bacterial diseases
Curr Opin Infect Dis. 24(5):457-63, 2011.
112. Neuberger A, Schwartz E,
Clostridium difficile infection after malaria chemoprophylaxis with doxycycline:
Is there an association?
Travel Medicine and Infectious Disease 9(5):243-5 , 2011
International Missions
113. Schwartz E., Pener H., Issa M.S., Golenser J.
An overview of the malaria situation in Zanzibar.
J. of Community Health 22, 33-44, 1997.
-12
Short CV- ELI SCHWARTZ, MD, DTMH
114. Schwartz E., Paul F., Pener H., Almog S., Rotenberg M., Golenser J.
Malaria antibodies and mefloquine levels among United Nations troops in Angola.
J. Travel Medicine. 8:113-116, 2001
115. Schwartz E.
Help Tsunami Victims – be a Tourist!
J. of Travel Medicine , 12; 120-21, 2005
116. Schwartz E.
The aftermath of the Tsunami
Harefuah,- 144: 160-162, 2005
117. Katz U, Zilberman N, Rusinek I, Schwartz E
Israeli mission to Equatorial Guinea during a cholera outbreak
Harefuah,-, 144:, 306-9, 2005
118. Katz U, Zilberman N, Rusinek I, Schwartz E
Caring for the Care-givers
J. of Travel Medicine , 13; 63-6, 2006
119. Neuberger A., Tenenboim S, Golos M, Pex R, Krakowsky Y, Urman M,
Vernet S, Schwartz E.
Infectious diseases seen in a primary care clinic in Leogane, Haiti
Am J Trop Med Hyg. 86(1):11-5, 2012
Travel Medicine –Epidemiology & general
120. The GeoSentinel Group. Geosentinel:The Global Emerging Infections Sentinel
Network of the International Society of Travel Medicine.
J. of Travel Medicine. 6: 94-98, 1999.
121. Alkan M.L., Hermesh H., Simerman J., Atzmon B., Peri G., Schwartz E..
Severe psychiatric disorders during trips to the Far East.
Harefu’a . 136, 940-942, 1999.
122. Schwartz E. Witztum E., Mumcuoglu K.Y
Travel as a trigger for shared delusional parasitosis.
Travel Medicine. 8;26-28, 2001
123. M.E. Wilson, Eli Schwartz
Fever in returening travelers. (Chapter)
In: Keystone JS, ed. Travel Medicine. Edinburgh: Mosby 2004
124. Steinlauf S, Segall G, Sidi Y, Schwartz E
Epidemiology of Travel -Related Hospitalization
J. of Travel Medicine – 12: 136-141, 2005
-13
Short CV- ELI SCHWARTZ, MD, DTMH
125. Wilson ME, Weld L Boggild A, Keystone JS., Kain KC, Sonnenburg F,
Schwartz E for the GeoSentinel Surveillance Network
Fever in Returned Travelers :Results from the GeoSentinel Surveillance
Network Clinical Infectious Diseases-, 44 (12) 1560-8. 2007
126. Freedman DO, Weld LH, Kozarsky PE, Fisk T, Robins R, von Sonnenburg F,
Keystone JS, Pandey P, Cetron MS; GeoSentinel Surveillance Network.
Spectrum of disease and relation to place of exposure among ill returned travelers.
N Engl J Med. ;354:119-30. 2006
127. Wilson ME, Weld L Boggild A, Keystone JS., Kain KC, Sonnenburg F, Schwartz E
Fever in Returned Travelers :Results from the GeoSentinel Surveillance Network
Clinical Infectious Diseases-, 44 (12) 1560-8. 2007
128. Greenwood Z , Black J Weld L, O’Brien D, Leder K, Von Sonnenburg F,
Pandey P, Schwartz E, Connor B, Brown G, Freedman D, Torresi J, for the
GeoSentinel Surveillance Network.
Gastrointestinal Infection Among International Travelers Globally
J. of Travel Medicine , 15(4):221-8. ; 2008
129. Lederman E, Weld L, Elyazar I, Kes M , Sonnenburg F, Loutan L, Schwartz E.
Keystone J.
Dermatologic Conditions of the Ill Returned Traveler: An Analysis from the
GeoSentinel Surveillance Network”
Int J Infect Dis. 12(6):593-602; 2008
130. Leshem E, Pandey P.,. Shlim DR, Hiramatsu K, Sidi Y , Schwartz E
Clinical Features of Patients with Severe Altitude Illness in Nepal
J. Travel Med- 15(5):315-22. 2008
131. Nicolls DJ., Weld L, Schwartz E , Reed C, Sonnenburg F, Kozarsky P, for the
GeoSentinel Surveillance Network
Schistosomiasis in Travelers: a review of patients reported to the GeoSentinel
Surveillance Network.
Am J Trop Med Hyg. 79(5):729-34. 2008
132. Steinlauf S, Yahalom, Schwartz E , Shinar E, Segal G, Sidi Y
Epidemiology of HTLV1 infection among blood donors in Israel: A Global
Implication?
Emerging Infectious Diseases.. 15(7):1116-8. 2009
133. Hagmann S, , Neugebauer R, , Schwartz E, Perret C, Castelli F, Barnett E, Stauffer
WM., for the GeoSentinel Surveillance Network*
Illness in Children after International Travel:Analysis from the GeoSentinel
Surveillance Network
Pediatrics -accepted
-14
Short CV- ELI SCHWARTZ, MD, DTMH
134. Chen LH., Wilson ME., Davis X, Loutan L, Schwartz E, Keystone J, Hale D, Lim PL,
McCarthy A, Gkrania-Klotsas E, Schlagenhauf P, for the GeoSentinel Surveillance
Network
Risk of illness in long-term travelers presenting to the GeoSentinel Surveillance
Network
Emerging Infectious Diseases.. 15(11):1773-82. 2009
135. Schlagenhauf P,. Chen LH,. Wilson ME , Freedman DO, Tcheng D., Schwartz E,
Pandey P, Weber R, Nadal D, Berger C, Sonnenburg F, Keystone J, Leder K.
Sex and Gender Differences in Travel-Associated Illness
Clin Infect Dis. 50(6):826-832; 2010
136. Boggild AK, Castelli F, Gautret P, Torresi J, von Sonnenburg F, Barnett ED,
Greenaway CA, Lim PL, Schwartz E, Wilder-Smith A, Wilson ME; for the
GeoSentinel Surveillance Network
Vaccine Preventable Diseases in Returned International Travelers: Results from the
GeoSentinel Surveillance Network
Vaccine 2010 – 28(46):7389-95
137. Levy T, Kivity S, Schwartz E.
Protracted rheumatologic manifestations in travelers].
Harefuah. 2010 Sep;149(9):604-8, 618. Hebrew-Review
138. Leshem E, Schwartz E.
Fever in returned travelers].
Harefuah. 2010 Sep;149(9):598-603, 618. Hebrew-Review
139. Mizrachi E, Steinlauf S, Schwartz E.
Morbidity of Israeli travelers after traveling to developing countries].
Harefuah. 2010 Sep;149(9):563-7, 621. Hebrew.
140. Stienlauf S, Meltzer E, Leshem E, Rendi-Wagner P, Schwartz E.
The profile of Israeli travelers to developing countries: perspectives of a travel clinic].
Harefuah. 2010 Sep;149(9):559-62, 621. Hebrew.
141. Schwartz E.
Travel medicine: an emerging discipline in medicine].
Harefuah. 2010 Sep;149(9):556-8. Hebrew-Editorial
142. Kivity S, Meltzer E, Bin H, Schwartz E.
Protracted rheumatic manifestations in travelers.
J Clin Rheumatol. 2011 Mar;17(2):55-8.
143. Ben-Horin S, Bujanover Y, Goldstein S, Nadler M, Lang A, Kopylov U, Katz L, Lahat
A, Schwartz E, Avidan B
Travel associated health risks for patients with inflammatory bowel disease
-15
Short CV- ELI SCHWARTZ, MD, DTMH
Clinical Gastroenterology and Hepatology 10(2):160-165
2012
144. Esposito DH, Han PV, Kozarsky PE, Walker PF, Gkrania-Klotsas E, Barnett ED,
Libman M, McCarthy AE, Field V, Connor BA, Schwartz E, MacDonald S, Sotir MJ;
GeoSentinel Surveillance Network
Characteristics and spectrum of disease among ill returned travelers from pre- and postearthquake Haiti: The GeoSentinel experience.
Am J Trop Med Hyg. 86:23-8 2012
145. Boggild AK, Castelli F, Gautret P, Torresi J, von Sonnenburg F, Barnett ED,
Greenaway CA, Lim PL, Schwartz E, Wilder-Smith A, Wilson ME; for the
GeoSentinel Surveillance Network
Latitudinal Patterns of Travel Among Returned Travelers with Influenza: Results
from the GeoSentinel Surveillance Network, 1997 —
2007
J. Travel Med 19(1):4-8, 2012
-16